Home Pharma Topics Policies & Regulations

Policies & Regulations

Promoting ‘Make In India’ Initiative in Pharmaceutical Sector

New Delhi, April 22, 2015: The Government has taken various measures to promote the ‘Make in India’ initiative in pharmaceutical sector. In this direction, the Government had constituted a Committee under the chairmanship of Secretary, Department of Health Research....

HOW MUCH DO CONSUMERS REALLY KNOW ABOUT NON-STEROIDAL ANTI-INFLAMMATORY DRUGS?

New Delhi, May 30, 2014 - A presentation at this week’s National Medicines Symposium (NMS 2014) in Brisbane has highlighted the dangers of people taking common medicines such as non-steroidal anti-inflammatories (NSAIDs) without thinking about the potential risks or...

Novartis sues Biocon for patent breach

New Delhi , April 04,2014 - In what may turn out to be another major patent litigation between a multinational and a local pharmaceutical company, Swiss giantNovartis has dragged Biocon to court for allegedly infringing patent rights of its...

Quality Council of India , Government of India Approved & CertifiedPharma Programmes in GMP,...

New Delhi February 1st,2014: Programmes Offered(Quality Council of India , Government of India Approved & Certified) Post Graduate and Executive Diploma in i) Good Manufacturing Practices ii) Quality Assurance and Quality Control iii) Regulatory Affairs (Excellent mix...

Many Indian drug companies have been under USFDA scanner, especially for the Good manufacturing...

New Delhi October 29 2013:Recently many Indian drug companies have been under USFDA scanner, especially for the Good manufacturing practice (GMP) concerns. After many large drug players, now it seems to be the turn of Smruthi Organics to face...

U.S. drug industry upset with Indian policies on patents

Washington, September 30, 2013: The burgeoning Indian economy, which once appeared to be a potential key U.S. trade partner for decades to come, now has become a battleground over everything from brand-name drugs to big-budget Hollywood movies. India’s handling...

J&K Govt. makes State Drug Policy on par with its Industrial Policy

Jammu and Kashmir Government has green signalled a State Drug Policy based on rational use of drugs and promising to promote local manufacturers of pharmaceuticals in line with the State Industrial Policy. The policy, approved by the State cabinet...

Health ministry: “No, to market based drug pricing.”

Anxious about an across-the-board increase in the prices of essential drugs, the health ministry is seeking to pressurize the department of pharmaceuticals (DoP) to rethink its policy to change to market-based pricing of drugs. The current drug pricing regime...